NL-OMON45175已完成不适用
Capturing Changes in Cognition: developing a measure for progression in dementia - CatCh-Cog
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 560
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients: 1) A diagnosis of subjective cognitive decline, mild cognitive impairment (MCI) or dementia due to Alzheimer's Disease (AD) OR MCI or mild dementia due to Dementia with Lewy bodies (DLB); 2) MMSE >= 18; 3) Age >= 50; 4) Written informed consent; 5) Availability of a primary caregiver;Control group: age >= 50, cognitively normal
排除标准
- •Presence of a neurological disease other than AD or DLB; Presence of another major psychiatric disorder (according to Diagnostic and Statistical Manual of Mental Disorders, 4th version); Current abuse of alcohol or drugs; Currently participating in a clinical trial.
研究者
相似试验
进行中（未招募）
不适用
An observation study to measure cognitive function in patients with testicular cancer who go on to have chemotherapy after surgery compared to those who don not have chemotherapy.Cognitive functionCancer - TesticularMental Health - Studies of normal psychology, cognitive function and behaviourTesticular CancerACTRN12609000545268The University of Sydney154
已完成
不适用
Cognitive Changes With Adjuvant Therapy For Breast Cancer: A Longitudinal StudyCancer - Breastbreast cancerACTRN12609000893202Dr Michael Jameson200
尚未招募
不适用
A new perspective: Development of a cognitive behavioral therapeutic intervention for patients with remaining trauma related symptomspost-traumatic stress disorderNL-OMON53700Reinier van Arkelgroep (Den Bosch)44
已完成
不适用
The effect of flavonoids from cherries on memory and cognition in older adults with mild to moderate dementiaDiet and Nutrition - Other diet and nutrition disordersNeurological - DementiasDementiaACTRN12614001298606Illawarra Health and Medical Research Institute, University of Wollgongong60
进行中（未招募）
不适用
Monitoring des états cognitifs chez des sujets volontaires sains, sur 2 périodes, l'une avant et après administration d'une dose unique de Zolpidem, l'autre sans administration de traitementIt's a phase II study performed on healthy volonteers. Zolpidem (DCI) will be administered to the volunteers in order to inducing a drowsiness and a hypoattentiveness. Zolpidem is indicated in the treatment of occasional and transitory insomnia.MedDRA version: 9.1Level: LLTClassification code 10022437Term: InsomniaEUCTR2007-001688-31-FRarime company of the Mediscis group